Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease

Print Friendly, PDF & Email

CLINICAL TRIAL TARGETTING MITOCHONDRIAL MYOPATHIES: Xconomy San Diego — Reneo Pharmaceuticals has encouraging results from an early trial of a compound it is advancing for rare diseases characterized by impaired mitochondria—our cells’ energy generators—and the company says it is now designing a large global study of its drug candidate. Headed by president and CEO […]